Health Lev Facher STAT Plus: Upending Purdue Pharma’s settlement does little to help today’s opioid crisis, advocates say
Politics Rachel Cohrs Zhang and Sarah Owermohle STAT Plus: Biden and Trump spar over Medicare and abortion in a presidential debate filled with mistakes and falsehoods
Politics Rachel Cohrs Zhang, John Wilkerson, and Lizzy Lawrence STAT Plus: House panel passes bills to expand Medicare obesity drug coverage, cancer screening
D.C. Diagnosis Rachel Cohrs Zhang STAT Plus: Key health care topics to watch out for at the Biden-Trump debate
Health Isabella Cueto and J. Emory Parker By the numbers: America’s alcohol-related health problems are rising fast
Politics Rachel Cohrs Zhang STAT Plus: House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
Politics Sarah Owermohle STAT Plus: Supreme Court rejects challenge to Biden’s use of bully pulpit to fight Covid misinformation
Politics Casey Ross and Bob Herman Stop allowing MA plans to use AI to deny care without review, lawmakers urge CMS
Hospitals Mohana Ravindranath STAT Plus: HHS finalizes penalties for providers resorting to ‘information blocking’
Health tech Mohana Ravindranath STAT Plus: Federal judge rules in favor of hospital lobby in privacy lawsuit
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about FDA approval for Sarepta drug, MSF closing access campaign and more
Politics Sarah Owermohle STAT Plus: With sweeping NIH reform on the table, GOP previews new era of research scrutiny
A STAT Investigation Eric Boodman This federal rule didn’t stop coercive sterilization — but it blocked contraceptive access. Can it be fixed?
The Readout Elaine Chen STAT Plus: J.P. Morgan has officially jumped into early stage biotech investing
Politics Sarah Owermohle STAT Plus: Supreme Court unanimously rejects challenge to mailed abortion pills
Exclusive Rachel Cohrs Zhang Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea
Pharma Andrew Joseph STAT Plus: Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried
Business Casey Ross and Mohana Ravindranath STAT Plus: Why Google and Microsoft can’t defuse U.S. health care’s ticking cybersecurity problem
D.C. Diagnosis Sarah Owermohle FDA says it’s getting serious about illegal vapes. It’s still likely to get a tongue lashing.
Health tech Lizzy Lawrence STAT Plus: Medical device trials still don’t enroll enough women, study finds
Health Isabella Cueto ‘Concern is real’ about long Covid’s impact on Americans and disability claims, report says
Health tech Mohana Ravindranath STAT Plus: As Washington mulls new AI rules, startup leaders want a seat at the table
Politics Sarah Owermohle STAT Plus: Senators tussle over abortion policy against the backdrop of a presidential campaign